Genocea Biosciences (LTS:0A51) FCF Margin %: -5,988.89% (As of Mar. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0A51 Genocea Biosciences Inc LTS:0A51
16 GF Score
Price $0.00
View Full Analysis

What is Genocea Biosciences FCF Margin %?

Genocea Biosciences LTS:0A51 16 FCF Margin % is -5,988.89% as of Mar. 2022. GuruFocus rates LTS:0A51 with a GF Score™ of 16/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genocea Biosciences's Free Cash Flow for the three months ended in Mar. 2022 was $-16.17 Mil. Genocea Biosciences's Revenue for the three months ended in Mar. 2022 was $0.27 Mil. Therefore, Genocea Biosciences's FCF Margin % for the quarter that ended in Mar. 2022 was -5,988.89%.

As of today, Genocea Biosciences's current FCF Yield % is 0.00%.

The historical rank and industry rank for Genocea Biosciences's FCF Margin % or its related term are showing as below:

LTS:0A51' s FCF Margin % Range Over the Past 10 Years
Min: -2685.82   Med: 0   Max: 0
Current: -2685.82

LTS:0A51's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -81.28 vs LTS:0A51: -2685.82

Genocea Biosciences FCF Margin % Related Terms

Genocea Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Genocea Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genocea Biosciences FCF Margin % Chart

Genocea Biosciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -3,255.04 -2,965.14

Genocea Biosciences Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -724.56 0.00 -5,988.89

LTS:0A51 vs FNAM, BXRX, XSNX: FCF Margin % Comparison

For the Biotechnology subindustry, Genocea Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genocea Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genocea Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genocea Biosciences's FCF Margin % falls into.


LTS:0A51
16GF Score
Genocea Biosciences Inc LTS:0A51
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genocea Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genocea Biosciences's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-48.658/1.641
=-2,965.14 %

Genocea Biosciences's FCF Margin for the quarter that ended in Mar. 2022 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2022 )/Revenue (Q: Mar. 2022 )
=-16.17/0.27
=-5,988.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -5,988.89% mean?
Genocea Biosciences (LTS:0A51) has a FCF Margin % of -5,988.89% as of Mar. 2022. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genocea Biosciences and its competitors.
Is Genocea Biosciences' FCF Margin % too high?
Genocea Biosciences' current FCF Margin % is -5,988.89%. Overall, Genocea Biosciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Genocea Biosciences' FCF Margin % compare to FNAM and BXRX?
Genocea Biosciences' FCF Margin % of -5,988.89% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genocea Biosciences and its competitors. Genocea Biosciences's current FCF Margin % is -5,988.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genocea Biosciences stock overvalued right now?
Genocea Biosciences (LTS:0A51) has a current FCF Margin % of -5,988.89%. The current FCF Margin % is -5,988.89%. Genocea Biosciences' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Genocea Biosciences (LTS:0A51), the current FCF Margin % is -5,988.89% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genocea Biosciences Business Description

Address 100 Acorn Park Drive, Cambridge, MA, USA, 02140
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.
16GF Score

Get the complete analysis for LTS:0A51

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price